ACCRUFeR® (ferric maltol) is now available in Canada as a prescription oral treatment for ...
Kye Pharmaceuticals, Inc. ("Kye") announced today that ACCRUFeR® (ferric maltol) is now available across Canada. ACCRUFeR® is ...
pharmaphorum5 年
Shield Therapeutics soars on FDA approval of iron deficiency drug
The London-based company said the FDA had approved its lead product Ferracru/Accrufer (ferric maltol) in a market that could be worth $1 billion annually. The FDA approved the product for ...